Hemolytic disease of the fetus and newborn caused by anti-E
Objective: Maternal allo-antibody production is stimulated when fetal red blood cells are positive for an antigen absent on the mother′s red cells. The maternal IgG antibodies produced will pass through the placenta and attack fetal red cells carrying ...
Adiyyatu Sa′idu Usman +3 more
doaj +4 more sources
Rhesus-D zygosity and hemolytic disease of fetus and newborn
Alloimmunization against the Rhesus-D (RhD) antigen still remains as a major cause of hemolytic disease of fetus and newborn (HDFN). Determination of paternal RhDzygosity is performed by molecular testing and is valuable for the management of ...
Mostafa Moghaddam +3 more
doaj +4 more sources
Hemolytic disease of the fetus and newborn: Current trends and perspectives
The spectrum of hemolytic disease of the newborn has changed over the last few decades. With the implementation of Rhesus D immunoprophylaxis, hemolytic disease due to ABO incompatibility and other alloantibodies has now emerged as major causes of this ...
Basu Sabita +2 more
doaj +4 more sources
Hemolytic disease of the fetus and newborn caused by anti-D and anti-S alloantibodies: a case report [PDF]
Introduction Hemolytic disease of the fetus and newborn is most commonly caused by anti-D alloantibody. It is usually seen in Rhesus D (RhD)-negative mothers that have been previously sensitized.
Yousuf Rabeya +3 more
doaj +3 more sources
Hemolytic Disease of the Fetus and Newborn [PDF]
This thesis describes the pathogenesis, severity and treatment of hemolytic disease of the fetus and newborn.Sanquin Bloedvoorziening; Momenta Pharmaceuticals; Afdeling Verloskunde LUMC; Sanquin PlasmaproductenLUMC / Geneeskunde ...
Zwiers, C.
openaire +3 more sources
Variations and Opportunities in Postnatal Management of Hemolytic Disease of the Fetus and Newborn [PDF]
Importance Preventive efforts in pregnancy-related alloimmunization have considerably decreased the prevalence of hemolytic disease of the fetus and newborn (HDFN). International studies are therefore essential to obtain a deeper understanding of the postnatal management and outcomes of HDFN. Taken together with
Derek P. de Winter +96 more
core +10 more sources
HAEMOLYTIC DISEASE OF THE FETUS AND NEWBORN (HDFN) – CASE REPORT [PDF]
Background. Hemolytic disease of the fetus and newborn (HDFN) develops because of the passage of maternal erythrocyte alloantibodies through the placenta. These antibodies cause a reduction of the erythrocyte life span in the fetus and newborn.
Irena Bricl +2 more
doaj +1 more source
Oblivious of the yellow world – A newborn's telltale: ABO hemolytic disease of newborn
The increased destruction of fetal red cells can be immune (allo- or autoantibodies) or nonimmune (hemoglobinopathies, enzyme defects, and membrane defects) in nature and can cause shortened life span of red cells leading to hemolytic disease of the ...
Daljit Kaur +3 more
doaj +2 more sources
AB0-incompatibility of mother and fetus: the role of anti-glycan alloantibodies in the hemolytic disease of newborns [PDF]
The mother and fetus incompatibility due to Rh-factor, blood group or other blood factors can lead to hemolytic disease of the fetus and newborn (HDN). HDN is a clinical disease condition of the fetus and newborn as a result of hemolysis, when maternal ...
P. S. Obukhova +3 more
doaj +2 more sources
AB0 Hemolytic Disease of the Newborn Development in the Child with АВ (IV) Blood Group from the Mother with 0 (I) Blood Group: Clinical Case [PDF]
Background. Hemolytic disease of the newborn due to AB0 incompatibility typically develops when mother has 0 (I) blood group and prenatal child has А (II) or B (III).
Natalya L. Prokoptseva +3 more
doaj +2 more sources

